Verma A, Khan MA, Satrusal SR, Datta D. Emerging role of EZH2 in solid tumor metastasis. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer. 2024 Dec 24:189253.

Sinha A, Saini KK, Chandramouli A, Tripathi K, Khan MA, Satrusal SR, Verma A, Mandal B, Rai P, Meena S, Nengroo MA, Singh MP, Bhushan NS, Vasudevan M, Singhai A, Singh K, Mishra AK, Kamat SS, Datta D. ACSL4-mediated H3K9 and H3K27 hyperacetylation upregulates SNAIL to drive TNBC metastasis. Proc Natl Acad Sci U S A. 2024 Dec 24;121(52):e2408049121. doi: 10.1073/pnas.2408049121. Epub 2024 Dec 19. PMID: 39700137.

Jindal U, Mamgain M, Nath UK, Sharma I, Pant B, Sharma A, Gupta A, Rahman K, Yadav S, Singh MP, Mishra S. Targeting CERS6-AS1/FGFR1 axis as synthetic vulnerability to constrain stromal cells supported proliferation in Mantle cell lymphoma. Leukemia. 2024 Oct;38(10):2196-209.

Yadav A, Biswas T, Praveen A, Ganguly P, Bhattacharyya A, Verma A, Datta D, Ateeq B. Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer. Cancer Res Commun. 2023 Oct 9;3(10):2044-2061.(JIF:11.2)

Mahajan, A., Nengroo, M.A., Datta, D. and Katti, D.S., 2023. Converse modulation of Wnt/β-catenin signaling during expansion and differentiation phases of Infrapatellar fat pad-derived MSCs for improved engineering of hyaline cartilage. Biomaterials, 302, p.122296. (JIF:14)

K.K. Saini, P. Chaturvedi, A. Sinha, M.P. Singh, M.A. Khan, A. Verma, M.A. Nengroo, S.R. Satrusal, S. Meena, A. Singh, S. Srivastava, J. Sarkar, D. Datta*, Loss of PERK function promotes ferroptosis by downregulating SLC7A11 (System Xc⁻) in colorectal cancer, Redox Biology, 65, (2023) 102833. (JIF:11.4)

M. Chakravarti, S. Dhar, S. Bera, A. Sinha, K. Roy, A. Sarkar, S. Dasgupta, A. Bhuniya, A. Saha, J. Das, S. Banerjee, M. Vernekar, C. Pal, N. Alam, D. Datta, R. Baral, A. Bose, Terminally exhausted CD8+ T cells resistant to PD-1 blockade promote generation and maintenance of aggressive cancer stem cells, Cancer Res, 83 (2023). (JIF:13.64)

M. Maheshwari, N. Yadav, M. Hasanain, P. Pandey, R. Sahai, K. Choyal, A. Singh, M.A. Nengroo, K.K. Saini, D. Kumar, K. Mitra, D. Datta, J. Sarkar, Inhibition of p21 activates Akt kinase to trigger ROS-induced autophagy and impacts on tumor growth rate, Cell Death Dis, 13 (2022) 1045. (JIF:9.68)

A. Verma, A. Singh, M.P. Singh, M.A. Nengroo, K.K. Saini, S.R. Satrusal, M.A. Khan, P. Chaturvedi, A. Sinha, S. Meena, A.K. Singh, D. Datta*, EZH2-H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasis, Nat Commun, 13 (2022) 7344. (JIF:17.69)

M.A. Nengroo, M.A. Khan, A. Verma, D. Datta*, Demystifying the CXCR4 conundrum in cancer biology: Beyond the surface signaling paradigm, Biochim Biophys Acta Rev Cancer, 1877 (2022) 188790. (JIF:11.4)

M.A. Nengroo, A. Verma, D. Datta*, Cytokine chemokine network in tumor microenvironment: Impact on CSC properties and therapeutic applications, Cytokine, 156 (2022) 155916. (JIF:3.8)

R. Saklani, P.K. Yadav, M.A. Nengroo, S.L. Gawali, P.A. Hassan, D. Datta, D.P. Mishra, I. Dierking, M.K. Chourasia, An Injectable In Situ Depot-Forming Lipidic Lyotropic Liquid Crystal System for Localized Intratumoral Drug Delivery, Mol Pharm, 19 (2022) 831-842. (JIF:4.9)

A. Mahajan, A. Singh, D. Datta, D.S. Katti, Bioinspired Injectable Hydrogels Dynamically Stiffen and Contract to Promote Mechanosensing-Mediated Chondrogenic Commitment of Stem Cells, ACS Appl Mater Interfaces, 14 (2022) 7531-7550. (JIF:9.5)

A. Verma, A. Sinha, D. Datta*, Modulation of DNA/RNA Methylation by Small-Molecule Modulators and Their Implications in Cancer, Subcell Biochem, 100 (2022) 557-579.

S. Singh, R. Ali, J. Miyan, V. Singh, S. Meena, M. Hasanain, S. Bhadauria, D. Datta, J. Sarkar, W. Haq, Facile synthesis of rapamycin-peptide conjugates as mTOR and Akt inhibitors, Org Biomol Chem, 19 (2021) 4352-4358. (JIF:3.2)

M.A. Nengroo, S. Maheshwari, A. Singh, A. Verma, R.K. Arya, P. Chaturvedi, K.K. Saini, A.K. Singh, A. Sinha, S. Meena, A. Gupta, A. Mishra, J. Sarkar, D. Datta*, CXCR4 intracellular protein promotes drug resistance and tumorigenic potential by inversely regulating the expression of Death Receptor 5, Cell Death Dis, 12 (2021) 464. (JIF:9.68)

A.K. Singh, A. Verma, A. Singh, R.K. Arya, S. Maheshwari, P. Chaturvedi, M.A. Nengroo, K.K. Saini, A.L. Vishwakarma, K. Singh, J. Sarkar, D. Datta*, Salinomycin inhibits epigenetic modulator EZH2 to enhance death receptors in colon cancer stem cells, Epigenetics, 16 (2021) 144-161. (JIF:4.5)

M. Hasanain, R. Sahai, P. Pandey, M. Maheshwari, K. Choyal, D. Gandhi, A. Singh, K. Singh, K. Mitra, D. Datta, J. Sarkar, Microtubule disrupting agent-mediated inhibition of cancer cell growth is associated with blockade of autophagic flux and simultaneous induction of apoptosis, Cell Prolif, 53 (2020) e12749. (JIF:8.5)

A. Ganesher, P. Chaturvedi, R. Sahai, S. Meena, K. Mitra, D. Datta*, G. Panda*, New Spisulosine Derivative promotes robust autophagic response to cancer cells, Eur J Med Chem, 188 (2020) 112011. (JIF:4.5)

R. Tiwari, N. Manzar, V. Bhatia, A. Yadav, M.A. Nengroo, D. Datta, S. Carskadon, N. Gupta, M. Sigouros, F. Khani, M. Poutanen, A. Zoubeidi, H. Beltran, N. Palanisamy, B. Ateeq, Androgen deprivation upregulates SPINK1 expression and potentiates cellular plasticity in prostate cancer, Nat Commun, 11 (2020) 384. (JIF:17.69)

A. Shukla, R. Tyagi, S. Meena, D. Datta, S.K. Srivastava, F. Khan, 2D- and 3D-QSAR modelling, molecular docking and in vitro evaluation studies on 18beta-glycyrrhetinic acid derivatives against triple-negative breast cancer cell line, J Biomol Struct Dyn, 38 (2020) 168-185. (JIF:4.4)

M. Riyazuddin, A. Husain, G.R. Valicherla, S. Verma, A.P. Gupta, K.S. Praveena, A. Singh, S.R. Avula, K.V. Sashidhara, D. Datta, J.R. Gayen, Development and validation of LC-MS/MS method for quantification of novel PP2A - beta-catenin signalling inhibitor, S011-2111 in mice plasma: Application to its preclinical pharmacokinetic studies, J Chromatogr B Analyt Technol Biomed Life Sci, 1130-1131 (2019) 121829. (JIF:3.2)

J. Gour, S. Gatadi, R. Akunuri, M.V. Yaddanapudi, M.A. Nengroo, D. Datta, S. Chopra, S. Nanduri, Catalyst-free facile synthesis of polycyclic indole/pyrrole substituted-1,2,3-triazoles, Org Biomol Chem, 17 (2019) 8153-8165. (JIF:3.2)

P. Pandey, D. Singh, M. Hasanain, R. Ashraf, M. Maheshwari, K. Choyal, A. Singh, D. Datta, B. Kumar, J. Sarkar, 7-hydroxyfrullanolide, isolated from Sphaeranthus indicus, inhibits colorectal cancer cell growth by p53-dependent and -independent mechanism, Carcinogenesis, 40 (2019) 791-804. (JIF:4.7)

V.K. Pawar, Y. Singh, K. Sharma, A. Shrivastav, A. Sharma, A. Singh, J.G. Meher, P. Singh, K. Raval, A. Kumar, H.K. Bora, D. Datta, J. Lal, M.K. Chourasia, Improved chemotherapy against breast cancer through immunotherapeutic activity of fucoidan decorated electrostatically assembled nanoparticles bearing doxorubicin, Int J Biol Macromol, 122 (2019) 1100-1114. (JIF:8.2)

H.S. Cheruvu, N.K. Yadav, G.R. Valicherla, R.K. Arya, Z. Hussain, C. Sharma, K.R. Arya, R.K. Singh, D. Datta, J.R. Gayen, LC-MS/MS method for the simultaneous quantification of luteolin, wedelolactone and apigenin in mice plasma using hansen solubility parameters for liquid-liquid extraction: Application to pharmacokinetics of Eclipta alba chloroform fraction, J Chromatogr B Analyt Technol Biomed Life Sci, 1081-1082 (2018) 76-86. (JIF:3.2)

N. Sahu, S. Meena, V. Shukla, P. Chaturvedi, B. Kumar, D. Datta, K.R. Arya, Extraction, fractionation and re-fractionation of Artemisia nilagirica for anticancer activity and HPLC-ESI-QTOF-MS/MS determination, J Ethnopharmacol, 213 (2018) 72-80. (JIF:5.4)

A. Bhattacharjee, M. Hasanain, M. Kathuria, A. Singh, D. Datta, J. Sarkar, K. Mitra, Ormeloxifene-induced unfolded protein response contributes to autophagy-associated apoptosis via disruption of Akt/mTOR and activation of JNK, Sci Rep, 8 (2018) 2303. (JIF:4.99)

B.L. Hopkins, M. Nadler, J.J. Skoko, T. Bertomeu, A. Pelosi, P.M. Shafaei, K. Levine, A. Schempf, B. Pennarun, B. Yang, D. Datta, O. Bucur, K. Ndebele, S. Oesterreich, D. Yang, M. Giulia Rizzo, R. Khosravi-Far, C.A. Neumann, A Peroxidase Peroxiredoxin 1-Specific Redox Regulation of the Novel FOXO3 microRNA Target let-7, Antioxid Redox Signal, 28 (2018) 62-77. (JIF:6.6)

M.K. Hussain, D.K. Singh, A. Singh, M. Asad, M.I. Ansari, M. Shameem, S. Krishna, G.R. Valicherla, V. Makadia, S. Meena, A.L. Deshmukh, J.R. Gayen, M. Imran Siddiqi, D. Datta*, K. Hajela*, D. Banerjee*, A Novel Benzocoumarin-Stilbene Hybrid as a DNA ligase I inhibitor with in vitro and in vivo anti-tumor activity in breast cancer models, Sci Rep, 7 (2017) 10715. (JIF:4.99)

V.K. Pawar, Y. Singh, K. Sharma, A. Shrivastav, A. Sharma, A. Singh, J.G. Meher, P. Singh, K. Raval, H.K. Bora, D. Datta, J. Lal, M.K. Chourasia, Doxorubicin Hydrochloride Loaded Zymosan-Polyethylenimine Biopolymeric Nanoparticles for Dual 'Chemoimmunotherapeutic' Intervention in Breast Cancer, Pharm Res, 34 (2017) 1857-1871. (JIF:3.7)

S. Maheshwari, S.R. Avula, A. Singh, L.R. Singh, G.R. Palnati, R.K. Arya, S.H. Cheruvu, S. Shahi, T. Sharma, S. Meena, A.K. Singh, R. Kant, M. Riyazuddin, H.K. Bora, M.I. Siddiqi, J.R. Gayen, K.V. Sashidhara, D. Datta*, Discovery of a Novel Small-Molecule Inhibitor that Targets PP2A-beta-Catenin Signaling and Restricts Tumor Growth and Metastasis, Mol Cancer Ther, 16 (2017) 1791-1805. (JIF:6.0)

N.K. Yadav, R.K. Arya, K. Dev, C. Sharma, Z. Hossain, S. Meena, K.R. Arya, J.R. Gayen, D. Datta*, R.K. Singh*, Alcoholic Extract of Eclipta alba Shows In Vitro Antioxidant and Anticancer Activity without Exhibiting Toxicological Effects, Oxid Med Cell Longev, 2017 (2017) 9094641. (JIF:7.3)

A.P. Oluyori, A.K. Shaw, G.A. Olatunji, P. Rastogi, S. Meena, D. Datta, A. Arora, S. Reddy, S. Puli, Sweet Potato Peels and Cancer Prevention, Nutr Cancer, 68 (2016) 1330-1337. (JIF:2.9)

A.K. Singh, S.S. Chauhan, S.K. Singh, V.V. Verma, A. Singh, R.K. Arya, S. Maheshwari, M.S. Akhtar, J. Sarkar, V.M. Rangnekar, P.M.S. Chauhan, D. Datta*, Dual targeting of MDM2 with a novel small-molecule inhibitor overcomes TRAIL resistance in cancer, Carcinogenesis, 37 (2016) 1027-1040. (JIF:4.7)

M. Yadav, A.K. Singh, H. Kumar, G. Rao, B. Chakravarti, A. Gurjar, S. Dogra, S. Kushwaha, A.L. Vishwakarma, P.N. Yadav, D. Datta, A.K. Tripathi, N. Chattopadhyay, A.K. Trivedi, S. Sanyal, Epidermal growth factor receptor inhibitor cancer drug gefitinib modulates cell growth and differentiation of acute myeloid leukemia cells via histamine receptors, Biochim Biophys Acta, 1860 (2016) 2178-2190. (JIF:3.0)

A.K. Jha, S. Umar, R.K. Arya, D. Datta, A. Goel, Pyrano[3,2-c]julolidin-2-ones: a novel class of fluorescent probes for ratiometric detection and imaging of Hg(2+) in live cancer cells, J Mater Chem B, 4 (2016) 4934-4940. (JIF:7.0)

T. Mishra, R.K. Arya, S. Meena, P. Joshi, M. Pal*, B. Meena, D.K. Upreti, T.S. Rana, D. Datta*, Isolation, Characterization and Anticancer Potential of Cytotoxic Triterpenes from Betula utilis Bark, PLoS One, 11 (2016) e0159430. (JIF:3.7)

S. Faes, A. Planche, E. Uldry, T. Santoro, C. Pythoud, J.C. Stehle, J. Horlbeck, I. Letovanec, N. Riggi, D. Datta, N. Demartines, O. Dormond, Targeting carbonic anhydrase IX improves the anti-cancer efficacy of mTOR inhibitors, Oncotarget, 7 (2016) 36666-36680. (JIF:5.1)

G.R. Valicherla, K.M. Dave, A.A. Syed, M. Riyazuddin, A.P. Gupta, A. Singh, Wahajuddin, K. Mitra, D. Datta, J.R. Gayen, Formulation optimization of Docetaxel loaded self-emulsifying drug delivery system to enhance bioavailability and anti-tumor activity, Sci Rep, 6 (2016) 26895. (JIF:4.99)

T. Mishra, M. Pal, S. Meena, D. Datta, P. Dixit, A. Kumar, B. Meena, T.S. Rana, D.K. Upreti, Composition and in vitro cytotoxic activities of essential oil of Hedychium spicatum from different geographical regions of western Himalaya by principal components analysis, Nat Prod Res, 30 (2016) 1224-1227. (JIF:2.2)

R.K. Arya, A. Singh, N.K. Yadav, S.H. Cheruvu, Z. Hossain, S. Meena, S. Maheshwari, A.K. Singh, U. Shahab, C. Sharma, K. Singh, T. Narender, K. Mitra, K.R. Arya, R.K. Singh, J.R. Gayen, Datta*, Anti-breast tumor activity of Eclipta extract in-vitro and in-vivo: novel evidence of endoplasmic reticulum specific localization of Hsp60 during apoptosis, Sci Rep, 5 (2015) 18457. (JIF:4.99)

S. Kundooru, P. Das, S. Meena, V. Kumar, M.I. Siddiqi, D. Datta, A.K. Shaw, Substrate and stereocontrolled iodocycloetherification of highly functionalized enantiomerically pure allylic alcohols: application to synthesis of cytotoxic 2-epi jaspine B and its biological evaluation, Org Biomol Chem, 13 (2015) 8241-8250. (JIF:3.2)

A.K. Singh, R.K. Arya, S. Maheshwari, A. Singh, S. Meena, P. Pandey, O. Dormond, Datta*, Tumor heterogeneity and cancer stem cell paradigm: updates in concept, controversies and clinical relevance, Int J Cancer, 136 (2015) 1991-2000. (JIF:6.4)

V.K. Pawar, S.B. Panchal, Y. Singh, J.G. Meher, K. Sharma, P. Singh, H.K. Bora, A. Singh, D. Datta, M.K. Chourasia, Immunotherapeutic vitamin E nanoemulsion synergies the antiproliferative activity of paclitaxel in breast cancer cells via modulating Th1 and Th2 immune response, J Control Release, 196 (2014) 295-306. (JIF:10.8)

B. Chakravarti, T. Akhtar, B. Rai, M. Yadav, J. Akhtar Siddiqui, S.K. Dhar Dwivedi, R. Thakur, A.K. Singh, A.K. Singh, H. Kumar, K. Khan, S. Pal, S.K. Rath, J. Lal, R. Konwar, A.K. Trivedi, D. Datta, D.P. Mishra, M.M. Godbole, S. Sanyal, N. Chattopadhyay, A. Kumar, Thioaryl naphthylmethanone oxime ether analogs as novel anticancer agents, J Med Chem, 57 (2014) 8010-8025. (JIF:8.0)

S.S. Chauhan, A.K. Singh, S. Meena, M. Lohani, A. Singh, R.K. Arya, S.H. Cheruvu, J. Sarkar, J.R. Gayen, D. Datta, P.M. Chauhan, Synthesis of novel beta-carboline based chalcones with high cytotoxic activity against breast cancer cells, Bioorg Med Chem Lett, 24 (2014) 2820-2824. (JIF:2.9)

S. Krishna, D.K. Singh, S. Meena, D. Datta, M.I. Siddiqi, D. Banerjee, Pharmacophore-based screening and identification of novel human ligase I inhibitors with potential anticancer activity, J Chem Inf Model, 54 (2014) 781-792. (JIF:5.6)

J.K. Kanaujiya, S. Lochab, I. Kapoor, P. Pal, D. Datta, M.L. Bhatt, S. Sanyal, G. Behre, A.K. Trivedi, Proteomic identification of Profilin1 as a corepressor of estrogen receptor alpha in MCF7 breast cancer cells, Proteomics, 13 (2013) 2100-2112. (JIF:3.4)

A.K. Singh, R.K. Arya, A.K. Trivedi, S. Sanyal, R. Baral, O. Dormond, D.M. Briscoe, Datta*, Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12, Cytokine Growth Factor Rev, 24 (2013) 41-49. (JIF:13.0)

A. Basu, T. Liu, P. Banerjee, E. Flynn, D. Zurakowski, D. Datta, O. Viklicky, M. Gasser, A.M. Waaga-Gasser, J. Yang, S. Pal, Effectiveness of a combination therapy using calcineurin inhibitor and mTOR inhibitor in preventing allograft rejection and post-transplantation renal cancer progression, Cancer Lett, 321 (2012) 179-186. (JIF:9.7)

G.M. McMahon, D. Datta, S. Bruneau, M. Kann, M. Khalid, J. Ho, T. Seto, J.A. Kreidberg, I.E. Stillman, D.M. Briscoe, Constitutive activation of the mTOR signaling pathway within the normal glomerulus, Biochem Biophys Res Commun, 425 (2012) 244-249. (JIF:3.1)

S. Bruneau#, D. Datta#, J.A. Flaxenburg, S. Pal, D.M. Briscoe, TRAF6 inhibits proangiogenic signals in endothelial cells and regulates the expression of vascular endothelial growth factor, Biochem Biophys Res Commun, 419 (2012) 66-71. (#Equal Contribution) (JIF:3.1)

P. Banerjee, A. Basu, D. Datta, M. Gasser, A.M. Waaga-Gasser, S. Pal, The heme oxygenase-1 protein is overexpressed in human renal cancer cells following activation of the Ras-Raf-ERK pathway and mediates anti-apoptotic signal, J Biol Chem, 286 (2011) 33580-33590. (JIF:4.8)

A. Hoerning, K. Koss, D. Datta, L. Boneschansker, C.N. Jones, I.Y. Wong, D. Irimia, K. Calzadilla, F. Benitez, P.F. Hoyer, W.E. Harmon, D.M. Briscoe, Subsets of human CD4(+) regulatory T cells express the peripheral homing receptor CXCR3, Eur J Immunol, 41 (2011) 2291-2302. (JIF:5.4)

D. Datta, P. Banerjee, M. Gasser, A.M. Waaga-Gasser, S. Pal, CXCR3-B can mediate growth-inhibitory signals in human renal cancer cells by down-regulating the expression of heme oxygenase-1, J Biol Chem, 285 (2010) 36842-36848. (JIF:4.8)

M. Edelbauer, D. Datta, I.H. Vos, A. Basu, M.P. Stack, M.E. Reinders, M. Sho, K. Calzadilla, P. Ganz, D.M. Briscoe, Effect of vascular endothelial growth factor and its receptor KDR on the transendothelial migration and local trafficking of human T cells in vitro and in vivo, Blood, 116 (2010) 1980-1989. (JIF:20.3)

A. Basu, D. Datta, D. Zurakowski, S. Pal, Altered VEGF mRNA stability following treatments with immunosuppressive agents: implications for cancer development, J Biol Chem, 285 (2010) 25196-25202. (JIF:4.8)

A. Basu, A. Hoerning, D. Datta, M. Edelbauer, M.P. Stack, K. Calzadilla, S. Pal, D.M. Briscoe, Cutting edge: Vascular endothelial growth factor-mediated signaling in human CD45RO+ CD4+ T cells promotes Akt and ERK activation and costimulates IFN-gamma production, J Immunol, 184 (2010) 545-549. (JIF:4.4)

D. Datta, A.G. Contreras, A. Basu, O. Dormond, E. Flynn, D.M. Briscoe, S. Pal, Calcineurin inhibitors activate the proto-oncogene Ras and promote protumorigenic signals in renal cancer cells, Cancer Res, 69 (2009) 8902-8909. (JIF:13.64)

O. Dormond, A.G. Contreras, E. Meijer, D. Datta, E. Flynn, S. Pal, D.M. Briscoe, CD40-induced signaling in human endothelial cells results in mTORC2- and Akt-dependent expression of vascular endothelial growth factor in vitro and in vivo, J Immunol, 181 (2008) 8088-8095. (JIF:4.4)

D. Datta, A.G. Contreras, M. Grimm, A.M. Waaga-Gasser, D.M. Briscoe, S. Pal, Calcineurin inhibitors modulate CXCR3 splice variant expression and mediate renal cancer progression, J Am Soc Nephrol, 19 (2008) 2437-2446. (JIF:13.6)

A. Basu, A.G. Contreras, D. Datta, E. Flynn, L. Zeng, H.T. Cohen, D.M. Briscoe, S. Pal, Overexpression of vascular endothelial growth factor and the development of post-transplantation cancer, Cancer Res, 68 (2008) 5689-5698. (JIF:13.64)

D. Datta, O. Dormond, A. Basu, D.M. Briscoe, S. Pal, Heme oxygenase-1 modulates the expression of the anti-angiogenic chemokine CXCL-10 in renal tubular epithelial cells, Am J Physiol Renal Physiol, 293 (2007) F1222-1230. (JIF:4.2)

D. Datta, J.A. Flaxenburg, S. Laxmanan, C. Geehan, M. Grimm, A.M. Waaga-Gasser, D.M. Briscoe, S. Pal, Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells: relevance for the development of human breast cancer, Cancer Res, 66 (2006) 9509-9518. (JIF:13.64)

S. Laxmanan, D. Datta, C. Geehan, D.M. Briscoe, S. Pal, CD40: a mediator of pro- and anti-inflammatory signals in renal tubular epithelial cells, J Am Soc Nephrol, 16 (2005) 2714-2723. (JIF:13.6)